Home
Goodwin Procter LLP
Stephanie Dusaban Gonzales
Stephanie Dusaban Gonzales
Goodwin Procter LLP
Janssen v. Teva: Not An April Fool's Day Joke For Life Sciences Companies
15 Apr 2024 | United States
Artiva Biotherapeutics Receives FDA Fast Track Designation For AlloNK In Lupus Nephritis
11 Mar 2024 | United States
Sandoz To Acquire CIMERLI From Coherus For $170 Million
15 Feb 2024 | United States
USPTO Publishes Enablement Guidelines In View Of Amgen v. Sanofi
06 Feb 2024 | United States
Federal Circuit Remands To USPTO To Clarify Analysis Of Jepson-Format And Means-Plus-Function Claims In The Field Of Biotechnology
05 Feb 2024 | United States
District Court Grants Summary Judgment And Invalidates Patent In REGENXBIO v. Sarepta Litigation
11 Jan 2024 | United States
CRISPR Regulatory Updates
05 Jan 2024 | Worldwide
Biosimilar Deals Updates: Biocon, AstraZeneca
05 Jan 2024 | United States
European Biologics Regulatory Updates
23 Nov 2023 | European Union
Recent Adalimumab Biosimilar Developments
12 Oct 2023 | United States
Bristol-Myers Squibb And AstraZeneca Settle Anti-PD-L1 Antibody Product Litigation
03 Aug 2023 | United States
FDA Approves The Cyltezo Pen, An Autoinjector Option For Adalimumab
25 May 2023 | United States
FDA Guidance On Continuous Manufacturing Of Drug Substances And Drug Products
27 Apr 2023 | United States
Coherus Biosciences Announces Approval Of A Pegfilgrastim Autoinjector
22 Mar 2023 | United States
USPTO Launches The Cancer Moonshot Expedited Examination Pilot Program
23 Jan 2023 | United States
Samsung Bioepis Announces Approval Of Citrate-Free, High-Concentration Adalimumab Biosimilar In Canada
12 Jan 2023 | United States
Decision Time: The Unified Patent Court Begins In 2023
21 Dec 2022 | United States
Update On Celltrion's Infliximab Biosimilar
07 Dec 2022 | United States
Janssen Files BPCIA Complaint Against Amgen Regarding Ustekinumab
05 Dec 2022 | United States
STADA And Xbrane Announce Approval Of Ranibizumab Biosimilar In Europe
15 Nov 2022 | Worldwide
< 1 2 >
Contact Details
Los Angeles
Email Website
Los Angeles
United States

  © Mondaq® Ltd 1994 - 2024. All Rights Reserved.